Article

Design-of-Experiment Software Added to Bioreactor Systems

Chemometric software integrated with process-development microbioreactors enhances process optimization and scale-up.

The 2015 version of the the ambr systems for bioreactor process development from Sartorius Stedim Biotech (SSB) will be supplied with integrated BioPAT MODDE Software for design of experiments (DoE), powered by Umetrics, SSB announced in a Feb. 25, 2015 press release. The software will allow bioprocess scientists to implement DoE into their workflow for simpler process optimization and scale-up to larger single-use BIOSTAT pilot and manufacturing-scale bioreactors, making bioprocess development faster and more cost-effective. The software will be supplied with the ambr 15 microbioreactor system for cell-line development and early process optimization and the ambr 250 system, which is a high-throughput scale-down model for process development.

The integrated DoE software can be used to establish a design space where relevant bioprocessing conditions are varied simultaneously. Users can configure DoE experiments using work packets that are exported from the software to the ambr system, thus configuring each microbioreactor with its own DoE-defined bioprocessing parameters. The data generated from ambr, including offline analytics, is analyzed within the software to identify critical process parameters, optimize bioprocessing conditions, and define a robust design space for implementation in larger single-use BIOSTAT pilot and manufacturing-scale bioreactors. This extended DoE functionality is also available to existing ambr users.

Source: Sartorius Stedim Biotech

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More